Clinical study protocol for the treatment of moderate to severe persistent allergic rhinitis with lung-deficiency-related cold type by fire acupuncture at the Inner Yingxiang(Ex-HN09) point

Beijing Hospital of Traditional Chinese Medicine, Capital Medical University0 个研究点开始时间: 待定最近更新: 2023年2月20日

适应症

试验速览

暂无简介。

•1.Meets the agnostic criteria for allergic rhinitis with lung-deficiency-related cold type.
•2.Meets the diagnostic criteria for persistent allergic rhinitis with symptom onset = 4 d/week and = 4 consecutive weeks.
•3.Meets the diagnostic criteria for moderate-to-severe allergic rhinitis with severe or serious symptoms that have a significant impact on the quality of life.
•4.Age between 18 and 65 years old with a disease duration of = 1 year.
•5.Voluntary completion of the informed consent form, agreeing to participate in the clinical subjects.

•1.Age <18 years or >65 years.
•2.Patients with combined sinusitis, upper respiratory tract infection or asthma.
•3.Patients with known presence or suspected allergy to loratadine or contraindications to its use.
•4.Have used antihistamines, oral or nasal spray glucocorticoids, decongestants, mast cell membrane stabilizers, leukotriene antagonists, etc. within 14 days.
•5.Patients who have received specific immunotherapy or systemic glucocorticoid treatment within the last year.
•6.Patients who have received traditional medical internal or external therapies such as acupuncture, moxibustion, tui na or oral Chinese medicine within the last 1 month for allergic rhinitis.
•7.Combined with tumors, serious heart, liver, kidney and other vital organs, blood and endocrine diseases.
•8.Pregnancy, pregnancy preparation, breastfeeding plan within the last six months.
•9.Those who have not signed informed consent.

发起方

Beijing Hospital of Traditional Chinese Medicine, Capital Medical University